Task: Answer the multiple-choice question.
Query: Which drug exhibits a 16.102\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: COc1ccc(C(=O)C[n+]2ccc3c(c2)nc(-c2cc(OC)c(OC)cc2OC)n3C)cc1.[Br-]
b: COc1ccc(NC2CCCN(C(=O)CCc3ccncc3)C2)cc1OC
c: O=[N+]([O-])c1cc(C(F)(F)F)ccc1NN=C1CCCC1
Answer: b. COc1ccc(NC2CCCN(C(=O)CCc3ccncc3)C2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC2CCCN(C(=O)CCc3ccncc3)C2)cc1OC
COc1ccc(NC2CCCN(C(=O)CCc3ccncc3)C2)cc1OC
1-[3-(3,4-dimethoxyanilino)piperidin-1-yl]-3-pyridin-4-ylpropan-1-one